PulseGLP Wiki
Compounded GLP-1 Advertising Risk Signals
A living reference for compounded semaglutide and tirzepatide advertising claims, disclosures, and observed ad-market language.
Last updated: 2026-05-26. This page is generated from the PulseGLP second brain and should be treated as market-intelligence context, not medical or legal advice.
Current Signal Snapshot
- 3,073 matching patient-evidence rows in the last 180 days.
- 913 matching Meta ad observations in the last 180 days.
- 320 matching FDA warning-letter findings in the enforcement corpus.
- Newest matching patient evidence was observed 5/22/2026.
- Newest matching ad observation was seen 5/22/2026.
Patient Evidence Patterns
- Top drug/entity mix in sampled evidence: Tirzepatide (17), Semaglutide (10), Wegovy (4), Mounjaro (2), Zepbound (2), Ozempic (1).
- Highest-volume sampled sources: r/Tirzepatide (17), r/Semaglutide (10), r/WegovyWeightLoss (4), r/Zepbound (2), r/Mounjaro (1), r/Mounjaro UK (1).
- Classification mix in sampled evidence: Analytical (15), Risk-Alert (10), Neutral-Low (7), Positive (4).
- Use Ask Pulse to inspect source-level citations before turning this signal into campaign copy, clinical workflow changes, or compliance guidance.
FDA And Compliance Context
- Most common matching warning-letter finding types: other-fda-cited-claim (11), product-sourcing-ambiguity (2), sameness-or-fda-approval-implication (2), unapproved-product-risk (2), unsupported-efficacy-or-safety-claim (1).
- Recent companies/products represented in matching findings include Mile High Compounds LLC / Drugs; Belle Health LLC dba Belle / Drugs; Dripgym Mobile Parent, LLC dba Amp Health / Drugs.
- PulseGLP tracks potential FDA-cited language patterns; it does not determine whether a claim is compliant or non-compliant.
Ad Market Signals
- Advertisers appearing in the sampled matching set: Beyond the Scale (3), Zimmerman Reed (3), American Health Report (2), 40 Plus & Fabulous (1), Bailey Health Solutions (1), BeSlimMD Weight Loss (1).
- Creative Intelligence can inspect the underlying ads for risk-level labels, themes, landing URLs, and repeated positioning patterns.
- Ad counts reflect observed library rows and can include deduped or updated observations from recovered collection runs.
How Ask Pulse Uses This Page
- Ask Pulse retrieves this page as durable context before it looks at fresh raw evidence.
- The page helps keep answers consistent across repeated questions about the same topic.
- Raw evidence citations are still required for specific factual claims or patient-language details.